Observational studyAnnals of Saudi medicine
Community-acquired
Observational study in Annals of Saudi medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCommunity-acquired pneumonia (CAP) caused by
objectivesTo compare the clinical, laboratory, radiological, and prognostic characteristics of community-acquired
designSingle-center retrospective observational cohort study. SETTINGS: Department of Pulmonology, Kocaeli City Hospital, İzmit, Kocaeli, Türkiye from April 2023 to March 2025. PATIENTS AND
methodsAdult patients hospitalized with CAP and positive sputum cultures were reviewed. Hospital-acquired and ventilator-associated pneumonias were excluded. Patients were classified as CAECP or Other-CAP. Demographic, clinical, laboratory, radiological, CURB-65, Pneumonia Severity Index (PSI), and outcome data were compared. A targeted multivariable logistic regression model adjusted for age and malignancy evaluated 90-day mortality.
main outcome measuresIn-hospital mortality, 90-day mortality, intensive care unit admission, and hospital length of stay. SAMPLE SIZE: Sixty-eight patients (37 CAECP, 31 Other-CAP).
resultsMedian age (69 [interquartile range, IQR 50.7-71] vs 67 [56-70] years;
conclusionCAECP resembles other CAP etiologies at presentation, but is associated with longer hospitalization and markedly higher 90-day mortality despite similar baseline severity scores. LIMITATIONS: Single-center retrospective design, small sample size, and limited number of mortality events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.